SFM
Sphera Funds Management’s Larimar Therapeutics LRMR Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $568K | Sell |
196,635
-169,669
| -46% | -$490K | 0.13% | 90 |
|
|
2025
Q1 | $788K | Sell |
366,304
-89,300
| -20% | -$192K | 0.18% | 95 |
|
|
2024
Q4 | $1.76M | Buy |
455,604
+41,126
| +10% | +$159K | 0.32% | 82 |
|
|
2024
Q3 | $2.71M | Buy |
414,478
+102,009
| +33% | +$668K | 0.43% | 64 |
|
|
2024
Q2 | $2.27M | Buy |
+312,469
| New | +$2.27M | 0.31% | 79 |
|
|
2021
Q2 | – | Sell |
-100,000
| Closed | -$1.46M | – | 147 |
|
|
2021
Q1 | $1.46M | Buy |
+100,000
| New | +$1.46M | 0.11% | 121 |
|
|
2020
Q4 | – | Sell |
-342,064
| Closed | -$5.19M | – | 118 |
|
|
2020
Q3 | $5.19M | Sell |
342,064
-54,723
| -14% | -$830K | 0.51% | 52 |
|
|
2020
Q2 | $5.1M | Sell |
396,787
-2,764,775
| -87% | -$35.5M | 0.48% | 47 |
|
|
2020
Q1 | $2.43M | Buy |
3,161,562
+2,813,892
| +809% | +$2.17M | 0.3% | 48 |
|
|
2019
Q4 | $386K | Buy |
+347,670
| New | +$386K | 0.03% | 79 |
|
|
2019
Q1 | – | Sell |
-380,000
| Closed | -$1.88M | – | 109 |
|
|
2018
Q4 | $1.88M | Sell |
380,000
-50,000
| -12% | -$248K | 0.21% | 74 |
|
|
2018
Q3 | $5.03M | Sell |
430,000
-50,000
| -10% | -$585K | 0.58% | 46 |
|
|
2018
Q2 | $4.91M | Buy |
+480,000
| New | +$4.91M | 0.68% | 38 |
|
|
2015
Q4 | – | Sell |
-40,000
| Closed | -$1.28M | – | 119 |
|
|
2015
Q3 | $1.28M | Buy |
+40,000
| New | +$1.28M | 0.16% | 103 |
|
|
2015
Q1 | – | Sell |
-72,100
| Closed | -$2.22M | – | 148 |
|
|
2014
Q4 | $2.22M | Sell |
72,100
-25,000
| -26% | -$771K | 0.38% | 80 |
|
|
2014
Q3 | $1.91M | Buy |
+97,100
| New | +$1.91M | 0.24% | 83 |
|